The Duke-Industry Statistics Symposium (DISS) will be held virtually March 29-31, 2023 with the theme “Empower Clinical Development by Harnessing Data from Diverse Sources”.
Clinical development commonly incorporates qualitative information outside of clinical trial settings in treatment evaluations and clinical assessments. Such qualitative information includes prior clinical experience and expert opinions. More recently, new study designs and methods that allow systematically harnessing information from diverse sources of external data, have been proposed. Leveraging external data sources, from historical trials in similar patient populations or with same class treatments to real-world data and real-world evidence, is expected to drastically improve the efficiency of clinical developments.
This symposium is free for all Duke B&B, DCRI, and DCI faculty, staff and graduate students who have a valid Duke email. To obtain the promo code for free symposium registration, please pay attention to the email announcements within the department, or contact directly Judy Adkins at judy.adkins@duke.edu.
Information regarding the program schedule, including sessions, speakers, talk abstracts, poster submission, and registration, can be found on the DISS2023 Website. The first day of the virtual symposium will be devoted to short courses. The following day and a half will consist of keynote speeches, parallel sessions, and poster lightning talk sessions. Keynote speakers for the symposium will be Dr. John Concato, the Associate Director for Real-World Evidence Analytics in the Office of Medical Policy, FDA/CDER, and Dr. Demissie Alemayehu, the Vice President of Pfizer Biostatistics.
The virtual symposium will be free to all undergraduate and graduate students with majors in statistics, biostatistics, and data sciences with viable credentials. We are encouraging poster submissions for the symposium, which is a great opportunity for graduate students or young researchers to share their research work. The poster can be any topic that involves the use of quantitative methods in pharmaceutical developments. The deadline to submit an e-poster/slides is March 15, 2023, 5pm ET.
The Duke-Industry Statistics Symposium is organized by the Department of Biostatistics and Bioinformatics, Duke University School of Medicine, and co-sponsored by Amgen, ASA-NC Chapter, BeiGene, Boehringer- Ingelheim, Genentech, ICSA, IQVIA, Janssen, Journal of Biopharmaceutical Statistics, Pfizer, PAREXEL, PPD (part of Thermo Fisher Scientific), SAS, UCB and ViiV. This series of symposiums was established ten years ago to discuss challenging issues and recent advances related to the clinical development of drugs, biologics, and devices and to promote research and collaboration among statisticians from industry, academia, and regulatory agencies.
We are excited to offer DISS2023 and look forward to seeing you virtually on March 29-31, 2023.
The Organizing Committee of DISS2023